On the other, I wasn't so much rebelling as I was embracing the oppressive, misogynistic diet industrial complex all over again
But at a time when we should be promoting health care access, the health plan for New York City employees recently made a surprising decision with far-reaching repercussions: they announced that they will discontinue coverage of GLP-1 weight loss medicines for its 400,000 public employees
Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, et al
Ultimately, it is up to them to make a risk-benefit and quality of life decision on whether they want to take the medicine
[7] These are real, well-conducted studies, and they establish something specific and limited: in healthy volunteers, CJC-1295 with DAC raises GH and IGF-1 for an extended period and was reported as generally well tolerated over the short term
Sickle Cell Disease: The only medical use of glutamine approved by the FDA is at this time used to treat sickle cell disease (SCD)